Why digital advocacy is the key to success
Every day, research institutions, biotechnology, pharmaceutical, device and diagnostic companies and patient advocacy groups are seeking to improve the health of people around the world. The novel coronavirus hasn’t changed that mission, but it has thrust it into the spotlight.
COVID-19 has created an industrywide sense of urgency. That urgency has fueled innovation, and, on a daily basis, we hear announcements of vaccines in early-stage development or updates to cell and gene therapies that have been in the R&D pipeline.
It’s never been more important for the industry to understand the benefits of a coordinated digital approach to communications.
These messages of discovery, innovation and optimism can’t fall on deaf ears. It’s never been more important for the industry to understand the benefits of a coordinated digital approach to communications — and that won’t change when we return to normal.
- Built for speed: Digital advocacy campaigns create and motivate supporters quickly online, saving time and money. Messaging can be stood up in a matter of hours, and soon you’ll begin to see valuable insights to activate against.
- Data at the center of everything: The approach to digital advocacy is always rooted in data insights — allowing us to verify the maximum activation on advocacy issues and ensure that the messages are resonating. Unifying that data, through a dynamic, cloud-based dashboard, can give you a 30,000-foot view of your campaign and allow you to see what is and isn’t working in real time.
- Execute tactics from anywhere: From the comfort of their homes, patients have the ability to create videos, text messages, emails and social media posts. Patient advocacy groups can be mobilized to communicate with their legislators through petition signatures, direct messages and more to share individual and organizational voices. Through these tools, they can be sure that the needs of the patients they represent are shared and that the patient is the priority.
- Understanding who matters: Using tactics such as social network analysis, we can identify key influencers who share the same thoughts and visions, providing an aerial view of who is — and isn’t — influential to a campaign. These stakeholders often share the same mission and vision, and they are already proudly sharing their advocacy voice digitally.
- One team, one voice: By identifying opportunities to bring together the stakeholders in the life sciences industry, we can create a unified message. By following the voices and opinions of a mobilized constituency, pharmaceutical companies and legislators can be sure that the needs of patients, survivors and caregivers are met.
When time is of the essence, advocating as a unified voice across all channels encourages the discovery and delivery of treatments and cures to patients. Digital platforms can provide the information needed to move a product through the pipeline, identify an alliance to be built or advance an issue through government. These activations are allowing the entire life sciences industry to strive harder than ever during the COVID-19 pandemic to benefit patients and caregivers.
